1. Home
  2. IX vs BNTX Comparison

IX vs BNTX Comparison

Compare IX & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orix Corp Ads

IX

Orix Corp Ads

HOLD

Current Price

$29.23

Market Cap

27.6B

Sector

Finance

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$95.03

Market Cap

24.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IX
BNTX
Founded
1950
2008
Country
Japan
Germany
Employees
N/A
N/A
Industry
Diversified Financial Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.6B
24.8B
IPO Year
1970
2019

Fundamental Metrics

Financial Performance
Metric
IX
BNTX
Price
$29.23
$95.03
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$137.40
AVG Volume (30 Days)
166.8K
1.5M
Earning Date
02-09-2026
11-03-2025
Dividend Yield
2.58%
N/A
EPS Growth
11.37
N/A
EPS
2.62
N/A
Revenue
$20,512,909,787.00
$3,698,814,972.00
Revenue This Year
$9.03
$2.03
Revenue Next Year
$3.38
N/A
P/E Ratio
$10.90
N/A
Revenue Growth
6.22
3.70
52 Week Low
$17.75
$81.20
52 Week High
$29.68
$129.27

Technical Indicators

Market Signals
Indicator
IX
BNTX
Relative Strength Index (RSI) 64.08 45.75
Support Level $29.22 $94.00
Resistance Level $29.59 $95.71
Average True Range (ATR) 0.26 1.74
MACD -0.04 0.51
Stochastic Oscillator 73.65 62.26

Price Performance

Historical Comparison
IX
BNTX

About IX Orix Corp Ads

ORIX Corp is a diversified financial services company with operations in Corporate Financial Services, Maintenance Leasing, Real Estate, PE Investment and Concession, Environment and Energy, Insurance, Banking and Credit, Aircraft and Ships, ORIX USA, ORIX Europe, Asia, and Australia and engages in various other fee businesses by providing products and services aligned with customer needs to its core customer base of domestic small and medium-sized enterprises. Orix's numerous divisions finance leases of large-ticket items like ships, airplanes, and technology equipment. The company generates the majority of its revenue from Corporate Financial Services and Maintenance Leasing operations and Real Estate operations.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: